April 6 (Reuters) - Biogen Inc BIIB.O:
BIOGEN - EXPECTS Q1 2026 GAAP AND NON-GAAP EPS IMPACT OF $0.19 FROM CHARGE - SEC FILING
BIOGEN - EXPECTS Q1 2026 $34 MILLION BOUGHT IN-PROCESS RESEARCH AND DEVELOPMENT, UPFRONT AND MILESTONE EXPENSE - SEC FILING